DrugPatentWatch Database Preview

Tolmar Company Profile

« Back to Dashboard

What is the competitive landscape for TOLMAR, and when can generic versions of TOLMAR drugs launch?

TOLMAR has twenty-five approved drugs.

There are five US patents protecting TOLMAR drugs.

There are sixty-seven patent family members on TOLMAR drugs in twenty-six countries and seventeen supplementary protection certificates in eight countries.

Summary for Tolmar

International Patents:	67
US Patents:	5
Tradenames:	18
Ingredients:	18
NDAs:	25
Patent Litigation for Tolmar:	See patent lawsuits for Tolmar

Drugs and US Patents for Tolmar

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tolmar	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	203688-001	Aug 25, 2016	AB	RX	No	No
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002		RX	Yes	Yes	8,840,916		Y
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021731-001	Dec 14, 2004		RX	Yes	Yes	8,840,916		Y
Tolmar	CALCIPOTRIENE	calcipotriene	CREAM;TOPICAL	200935-001	May 30, 2012	AB	RX	No	No
Tolmar	ATRIDOX	doxycycline hyclate	SYSTEM, EXTENDED RELEASE;PERIODONTAL	050751-001	Sep 3, 1998		RX	Yes	Yes
Tolmar	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	betamethasone dipropionate; calcipotriene hydrate	OINTMENT;TOPICAL	201615-001	Jan 14, 2013	AB	RX	No	No

Expired US Patents for Tolmar

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002	5,324,519
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002	5,599,552
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002	6,395,293
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021488-001	Feb 13, 2003	4,938,763
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021343-001	Jan 23, 2002	5,733,950
Tolmar Therap	ELIGARD	leuprolide acetate	INJECTABLE;SUBCUTANEOUS	021379-001	Jul 24, 2002	6,565,874

International Patents for Tolmar Drugs

Country	Patent Number	Estimated Expiration
Denmark	1267965
Czech Republic	303134
Hong Kong	1141459
World Intellectual Property Organization (WIPO)	0024374
Denmark	1322286
Australia	9293101

Supplementary Protection Certificates for Tolmar Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1458369	SPC/GB10/005	United Kingdom		PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
0162036	2000C/032	Belgium		PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
0526708	C300097	Netherlands		PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228
1458369	08C0024	France		PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
1458369	C01458369/01	Switzerland		PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009
1586316	SPC/GB11/054	United Kingdom		PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Tolmar
• Tolmar Therap